Vitality Watch

Dossier clinicaltrials trial early 02-oct-2026
Small or early-phase human trial or pilot study

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis

Key claim: Mother-of-pearl nutritional supplementation is being studied to prevent post-menopausal osteoporosis as HRT use has declined and fracture risk remains a major disability driver.

Abstract

Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity and mortality.

Given potential side effects, hormone replacement therapy is no longer recommended for menopausal women with risk of becoming osteoporotic. The very significant decrease in the use of these treatments is suspected of contributing to a resurgence in the incidence of osteoporotic fractures, particularly in women before the age of 70. There is a need for prevention of osteoporosis.

Why this matters

Mother-of-pearl nutritional supplementation is being studied to prevent post-menopausal osteoporosis as HRT use has declined and fracture risk remains a major disability driver.

Source

Link

Briefing card

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis
Stage: trial early · clinicaltrials · 02-oct-2026

Mother-of-pearl nutritional supplementation is being studied to prevent post-menopausal osteoporosis as HRT use has declined and fracture risk remains a major disability driver.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05571514

build build 880 · 2bcef25 · 2026-11-18